NCT04255121View on ClinicalTrials.gov

Bicarbonate Epidural Injection in Emergency Caesarian

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

December 13, 2020

Study Completion Date

February 26, 2021

Conditions
Emergency Caesarean
Interventions
DRUG

2% adrenaline lidocaine associated with 4.2% sodium bicarbonate

conversion of epidural analgesia into epidural anesthesia during an emergency caesarean using an alkalinization of adrenaline lidocaine solution

DRUG

2% adrenaline lidocaine

conversion of epidural analgesia into epidural anesthesia during an emergency caesarean using an adrenaline lidocaine solution

Trial Locations (1)

51092

Chu Reims, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT04255121 - Bicarbonate Epidural Injection in Emergency Caesarian | Biotech Hunter | Biotech Hunter